Bone mass in patients with rheumatoid arthritis.
作者信息
Laan R F, van Riel P L, van de Putte L B
机构信息
Department of Rheumatology, University Hospital, Nijmegen, The Netherlands.
出版信息
Ann Rheum Dis. 1992 Jun;51(6):826-32. doi: 10.1136/ard.51.6.826.
Abstract
摘要
相似文献
1
Bone mass in patients with rheumatoid arthritis.类风湿性关节炎患者的骨量
Ann Rheum Dis. 1992 Jun;51(6):826-32. doi: 10.1136/ard.51.6.826.
2
Bone metabolism and histomorphometric changes in rheumatoid arthritis.类风湿关节炎中的骨代谢与组织形态计量学变化
Scand J Rheumatol. 2002;31(5):285-90. doi: 10.1080/030097402760375188.
3
Osteomalacia and rheumatoid arthritis.骨软化症与类风湿关节炎。
Br J Rheumatol. 1989 Feb;28(1):84-5. doi: 10.1093/rheumatology/28.1.84-a.
4
Osteoporosis in rheumatoid arthritis--the clinical viewpoint.
Br J Rheumatol. 1991 Apr;30(2):82-4. doi: 10.1093/rheumatology/30.2.82.
5
6
Osteoporosis in rheumatoid arthritis and ankylosing spondylitis.类风湿关节炎和强直性脊柱炎相关的骨质疏松症。
Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S62-7.
7
Bone microarchitecture in osteoporotic men: universal or corticosteroid dependent?骨质疏松男性的骨微结构：是普遍存在的还是依赖于皮质类固醇的？
J Bone Miner Res. 2001 Jul;16(7):1374-5. doi: 10.1359/jbmr.2001.16.7.1374.
8
[Bone structure in rheumatoid arthritis].[类风湿关节炎中的骨骼结构]
Clin Calcium. 2013 Jul;23(7):983-91.
9
10
Osteoporosis in patients with rheumatic diseases.风湿性疾病患者的骨质疏松症。
Rheum Dis Clin North Am. 1994 Aug;20(3):561-76.
引用本文的文献
1
A quantitative assessment of the risk of falls in rheumatoid arthritis patients and determination of the risk factors.类风湿关节炎患者跌倒风险的定量评估及危险因素的确定。
Turk J Phys Med Rehabil. 2022 Jun 1;68(2):271-277. doi: 10.5606/tftrd.2022.7868. eCollection 2022 Jun.
2
Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis.类风湿关节炎患者骨密度与抗瓜氨酸化蛋白抗体及类风湿因子之间的关系
Eur J Rheumatol. 2019 Jan;6(1):29-33. doi: 10.5152/eurjrheum.2018.18099.
3
11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis.11β-羟类固醇脱氢酶 1 型调控慢性多关节炎中的滑膜炎、关节破坏和全身骨质丢失。
J Autoimmun. 2018 Aug;92:104-113. doi: 10.1016/j.jaut.2018.05.010. Epub 2018 Jun 8.
4
Characteristics and risk factors of rheumatoid arthritis in the United States: an NHANES analysis.美国类风湿关节炎的特征与风险因素：一项美国国家健康与营养检查调查分析
PeerJ. 2017 Nov 24;5:e4035. doi: 10.7717/peerj.4035. eCollection 2017.
5
Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.双膦酸盐用于预防和治疗风湿性疾病患者的骨质疏松症：一项系统评价和荟萃分析。
PLoS One. 2013 Dec 6;8(12):e80890. doi: 10.1371/journal.pone.0080890. eCollection 2013.
6
Effects of manganese deficiency on serum hormones and biochemical markers of bone metabolism in chicks.缺锰对雏鸡血清激素和骨代谢生化标志物的影响。
J Bone Miner Metab. 2013 May;31(3):285-92. doi: 10.1007/s00774-012-0417-6. Epub 2013 Feb 14.
7
Influence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patients.英夫利昔单抗对类风湿关节炎患者细胞因子网络和骨重建标志物的影响。
Yonsei Med J. 2013 Jan 1;54(1):183-8. doi: 10.3349/ymj.2013.54.1.183.
8
Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study.类风湿关节炎门诊患者跌倒的发生率及危险因素：一项为期1年的前瞻性研究。
Osteoporos Int. 2010 Nov;21(11):1825-33. doi: 10.1007/s00198-009-1150-4. Epub 2010 Jan 30.
9
Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis.依那西普降低类风湿关节炎患者尿中吡啶啉和脱氧吡啶啉水平以及血清中核因子κB受体活化因子配体的可溶性受体水平。
Clin Rheumatol. 2008 Sep;27(9):1093-101. doi: 10.1007/s10067-008-0870-8. Epub 2008 Mar 13.
10
Association of bone mineral density and vertebral deformity in patients with rheumatoid arthritis.类风湿关节炎患者骨密度与椎体畸形的关联
Rheumatol Int. 2007 Apr;27(6):579-84. doi: 10.1007/s00296-007-0323-8. Epub 2007 Feb 8.
本文引用的文献
1
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.随着年龄增长，四肢骨骼与中轴骨骼骨密度的差异变化：与脊柱骨质疏松症的关系。
J Clin Invest. 1981 Feb;67(2):328-35. doi: 10.1172/JCI110039.
2
Indomethacin inhibits bone resorption and lysosomal enzyme release from bone in organ culture.吲哚美辛可抑制器官培养中骨的骨吸收及溶酶体酶释放。
Scand J Rheumatol. 1980;9(3):149-56. doi: 10.3109/03009748009098147.
3
Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.接受隔日糖皮质激素治疗的成年人的骨质流失。与每日治疗的比较。
Arthritis Rheum. 1981 Jul;24(7):892-8. doi: 10.1002/art.1780240705.
4
5
Glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症
N Engl J Med. 1983 Aug 4;309(5):306-8. doi: 10.1056/NEJM198308043090509.
6
7
Fractures after rheumatoid arthritis. A population-based study.类风湿关节炎后的骨折。一项基于人群的研究。
Arthritis Rheum. 1984 Dec;27(12):1353-61. doi: 10.1002/art.1780271205.
8
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.泼尼松和地夫可特对人体矿物质代谢及甲状旁腺激素活性的影响。
Calcif Tissue Int. 1984 May;36(3):245-52. doi: 10.1007/BF02405325.
9
Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.长期使用皮质类固醇对骨干和干骺端骨量的影响。
J Clin Endocrinol Metab. 1974 Aug;39(2):274-82. doi: 10.1210/jcem-39-2-274.
10
The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state.糖皮质激素对类风湿关节炎患者骨量的影响。绝经状态的影响。
Arthritis Rheum. 1985 Apr;28(4):369-75. doi: 10.1002/art.1780280403.
Zotero 插件